Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (13)

2023

  1. Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review

    JACC: CardioOncology, Vol. 5, Núm. 6, pp. 715-731

  2. Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement

    eClinicalMedicine, Vol. 60

2022

  1. Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A

    Nature Communications, Vol. 13, Núm. 1

2021

  1. Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma

    Translational Lung Cancer Research, Vol. 10, Núm. 3, pp. 1327-1337

2020

  1. Clinical applications of molecular biomarkers in prostate cancer

    Cancers, Vol. 12, Núm. 6, pp. 1-25

  2. Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial

    Breast Cancer Research, Vol. 22, Núm. 1

2019

  1. Nintedanib plus letrozole in early breast cancer: A phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition

    Breast Cancer Research, Vol. 21, Núm. 1

2018

  1. Addition of durvalumab (Dur) upon progression to bevacizumab (Bev) maintenance in advanced HER2-negative (HERNEG) breast cancer (BC): Safety, efficacy and biomarkers

    Annals of Oncology, Vol. 29, pp. ix24

  2. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer

    Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483

2014

  1. Genética aplicada a la práctica clínica en trastornos del neurodesarrollo

    Revista de Neurologia, Vol. 58, Núm. SUPPL. 1

2012

  1. Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series

    Leukemia and Lymphoma, Vol. 53, Núm. 5, pp. 812-819

2009

  1. Analysis of the molecular expression profile of non small cell lung carcinoma associated to chronic obstructive pulmonary disease

    Histology and Histopathology, Vol. 24, Núm. 4, pp. 417-423

2006

  1. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas

    Human Pathology, Vol. 37, Núm. 8, pp. 1042-1049